- Aleksanterinkatu 46 C
- FI-00101 Helsinki
- Finland
- +358 9 6823 2100
- helsinki@eib.org
Contact us
More press releases
Finland: EIB lends €100 million to company Orion Pharma for new cancer and pain treatments
The European Investment Bank (EIB) is lending €100 million to Finnish pharmaceutical company Orion Pharma to develop new treatments for cancer, pain and other serious conditions with few treatment options.
€1,6 billion in EIB Group financing backed Finland's green transition and innovation in 2025
In 2025, the European Investment Bank (EIB) and the European Investment Fund (EIF), which together form the EIB Group, provided financing to Finnish public sector bodies and companies across a range of sectors, from sustainable transport and social infrastructure to advanced technologies and small business finance. The funding supported climate action, energy security, innovation and access to finance for startups and small and medium-sized enterprises. Total EIB Group financing amounted to around €1,6 billion and the support helped mobilise total investments in Finland of about €4.9 billion – equivalent to 1.8% of GDP or €868 per person.
Finland: startup Aisti secures €20 million EIB loan to advance sustainable noise-reducing panels
The European Investment Bank (EIB) is lending Aisti, a Finnish manufacturer of bio-based suspended ceiling panels that reduce noise, €20 million to increase its production capacity. The panels, known as acoustic tiles, are made from wood fibres. The material is patented and offers a sustainable alternative to traditional mineral wool tiles. It is designed for use in commercial buildings and in the public sector, such as schools and offices.